Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors for treating diseases characterized by atrial enlargement or remodeling

Inhibitors for treating diseases characterized by atrial enlargement or remodeling

US Patent 11135192 · Granted Oct 5, 2021

Estimated economic value: $26,976,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aldosterone synthase inhibitor2025
R-fadrozole for use in the treatment of aldostonerism2024
Aldosterone synthase inhibitor2022
Aldosterone synthase inhibitor2020
Inhibitors for treating diseases characterized by atrial enlargement or remodeli2018
Inhibitors for treating diseases characterized by atrial enlargement or remodeli2018
Inhibitors for treating diseases characterized by atrial enlargement or remodeli2016
Inhibitors for treating diseases characterized by atrial enlargement or remodeli2016
Use of an adrenal hormone-modifying agent2016
Tetrahydro-imidazo [1,5-A] pyridyin derivatives as aldosterone synthase inhibito2014
Use of an adrenal hormone-modifying agent2013
Heterocyclic spiro-compounds as aldosterone synthase inhibitors2011